Priority Date: 10.07.12 (US 201261669995P)

LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

  • Application ID: EP13817006
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
778.81
Headquarter in München and 1 office
active in Legal Services

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 128 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.07.2012 - Priority Date (US 201261669995P)
  • 16.01.2014 - Publication A1 (WO2014010232)
  • 20.05.2015 - Publication A1 (EP2872531)